Accenture (ACN) is set to release its third-quarter Fiscal 2025 results on June 20. The stock has dropped over 10% in the past year, primarily due to potential cuts in government contracts and broader economic uncertainty affecting client spending. Despite the recent dip, Wall Street analysts see over 10% upside for the professional services firm over the next 12 months. One such analyst is Tien Tsin Huang of J.P. Morgan, who remained upbeat about the stock ahead of the Q3 print. He increased his price target on the stock to $353 from $349, which suggests more than 13% upside from current levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
What to Expect from Accenture’s Q3 Earnings
Wall Street analysts expect Accenture to report earnings of $3.32 per share for the third quarter of Fiscal 2025, up 6% from the year-ago quarter. Meanwhile, analysts project Q3 revenues at $17.32 billion, according to the TipRanks Analyst Forecasts Page. This marks a year-over-year increase of over 5%.
Analysts’ Views Ahead of Q3 Print
J.P. Morgan expects Accenture to deliver in-line revenue and a slight earnings boost in its upcoming Q3 results, helped by favorable currency movements. The firm also believes the company will likely maintain its Fiscal 2025 revenue guidance at the midpoint.
Similarly, Stifel analyst David Grossman kept a Buy rating on Accenture with a $355 price target. He expects Q3 results to be mostly in line, with full-year guidance likely unchanged. While industry demand remains weak, the analyst believes Accenture’s strong global presence and wide service range help limit risk. He also sees potential support from progress on tariffs and a weaker U.S. dollar, though these factors are expected to have only a small impact on earnings.
Is ACN a Good Stock to Buy Now?
Turning to Wall Street, ACN has a Moderate Buy consensus rating based on 13 Buys and six Hold ratings assigned in the last three months. At $353.44, the average ACN price target implies 13.27% upside potential.
